$2.87
-0.29[-9.18%]
Last update: 10:33AM Get Real Time Here
T2 Biosystems
(NASDAQ:TTOO)T2 Biosystems Stock (NASDAQ:TTOO), Analyst Ratings, Price Targets, Predictions
T2 Biosystems Inc has a consensus price target of $0.86, established from looking at the 6 latest analyst ratings. The last 3 analyst ratings were released from Alliance Global Partners, Alliance Global Partners, and Canaccord Genuity on July 13, 2023, January 24, 2023, and October 14, 2022. With an average price target of $1.36 between Alliance Global Partners, Alliance Global Partners, and Canaccord Genuity, there's an implied -52.73% downside for T2 Biosystems Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Alliance Global Partners
Canaccord Genuity
BTIG
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for T2 Biosystems
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 07/13/2023 | TTOO | Buy Now | T2 Biosystems | $2.87 | -97.56% | Alliance Global Partners | Ben Haynor | $12 → $7 | Maintains | Neutral | Get Alert |
| 01/24/2023 | TTOO | Buy Now | T2 Biosystems | $2.87 | -47.74% | Alliance Global Partners | Ben Haynor | $220 → $150 | Maintains | Neutral | Get Alert |
| 10/14/2022 | TTOO | Buy Now | T2 Biosystems | $2.87 | -12.89% | Canaccord Genuity | Kyle Mikson | $1250 → $250 | Downgrade | Buy → Hold | Get Alert |
| 07/07/2022 | TTOO | Buy Now | T2 Biosystems | $2.87 | — | Alliance Global Partners | Ben Haynor | — | Downgrade | Buy → Neutral | Get Alert |
| 07/07/2022 | TTOO | Buy Now | T2 Biosystems | $2.87 | — | BTIG | Mark Massaro | — | Downgrade | Buy → Neutral | Get Alert |
| 02/18/2022 | TTOO | Buy Now | T2 Biosystems | $2.87 | -75.61% | Alliance Global Partners | Ben Haynor | → $3500 | Upgrade | Neutral → Buy | Get Alert |
FAQ
What is the target price for T2 Biosystems (TTOO)?
The latest price target for T2 Biosystems (NASDAQ: TTOO) was reported by Alliance Global Partners on July 13, 2023. The analyst firm set a price target for $0.07 expecting TTOO to fall to within 12 months (a possible -97.56% downside). 1 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for T2 Biosystems (TTOO)?
The latest analyst rating for T2 Biosystems (NASDAQ: TTOO) was provided by Alliance Global Partners, and T2 Biosystems maintained their neutral rating.
When was the last upgrade for T2 Biosystems (TTOO)?
The last upgrade for T2 Biosystems Inc happened on February 18, 2022 when Alliance Global Partners raised their price target to $0.7. Alliance Global Partners previously had a neutral for T2 Biosystems Inc.
When was the last downgrade for T2 Biosystems (TTOO)?
The last downgrade for T2 Biosystems Inc happened on October 14, 2022 when Canaccord Genuity changed their price target from $12.5 to $2.5 for T2 Biosystems Inc.
When is the next analyst rating going to be posted or updated for T2 Biosystems (TTOO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of T2 Biosystems, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for T2 Biosystems was filed on July 13, 2023 so you should expect the next rating to be made available sometime around July 13, 2024.
Is the Analyst Rating T2 Biosystems (TTOO) correct?
While ratings are subjective and will change, the latest T2 Biosystems (TTOO) rating was a maintained with a price target of $0.12 to $0.07. The current price T2 Biosystems (TTOO) is trading at is $2.87, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.